Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reissigl

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
World Journal of Urology|January 1, 1994
Androgen signal transduction and prostatic carcinomaH Klocker, Z Culig, F Kaspar, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2000
Prostate cancer screening in the Tyrol, Austria: experience and resultsW Horninger, A Reissigl, H Rogatsch, et al.
Urology|November 1, 1995
Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening studyA Reissigl, J Pointner, W Horninger, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2010
Bipolar versus monopolar TURP: a prospective controlled study at two urology centersD S Engeler, C Schwab, M Neyer, et al.
British Journal of Urology|February 1, 1995
Renal cell carcinoma extending into the vena cava: surgical approach, technique and resultsA Reissigl, G Janetschek, J Eberle, et al.
The Prostate|October 29, 1998
Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levelsW Horninger, A Reissigl, H Klocker, et al.
European Urology|May 15, 1999
Prostate cancer screening in Tyrol, Austria: experience and resultsW Horninger, A Reissigl, H Rogatsch, et al.
The Prostate|January 1, 1997
PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donorsA Reissigl, J Pointner, W Horninger, et al.
Urology|September 11, 2001
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, AustriaG Bartsch, W Horninger, H Klocker, et al.
Urology|December 1, 1996
Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screeningA Reissigl, H Klocker, J Pointner, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
World Journal of Urology|January 1, 1994
Androgen signal transduction and prostatic carcinomaH Klocker, Z Culig, F Kaspar, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2000
Prostate cancer screening in the Tyrol, Austria: experience and resultsW Horninger, A Reissigl, H Rogatsch, et al.
Urology|November 1, 1995
Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening studyA Reissigl, J Pointner, W Horninger, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2010
Bipolar versus monopolar TURP: a prospective controlled study at two urology centersD S Engeler, C Schwab, M Neyer, et al.
British Journal of Urology|February 1, 1995
Renal cell carcinoma extending into the vena cava: surgical approach, technique and resultsA Reissigl, G Janetschek, J Eberle, et al.
The Prostate|October 29, 1998
Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levelsW Horninger, A Reissigl, H Klocker, et al.
European Urology|May 15, 1999
Prostate cancer screening in Tyrol, Austria: experience and resultsW Horninger, A Reissigl, H Rogatsch, et al.
The Prostate|January 1, 1997
PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donorsA Reissigl, J Pointner, W Horninger, et al.
Urology|September 11, 2001
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, AustriaG Bartsch, W Horninger, H Klocker, et al.
Urology|December 1, 1996
Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screeningA Reissigl, H Klocker, J Pointner, et al.
Pageof 4